Utilization of Human Fibrinogen Concentrate During Proximal Aortic Reconstruction with Deep Hypothermic Circulatory Arrest

OBJECTIVE: Human fibrinogen concentrate (HFC) is approved by the Food and Drug Administration for use at 70 mg/kg to treat congenital afibrinogenemia. We sought to determine whether this dose of HFC increases fibrinogen levels in the setting of high-risk bleeding associated with aortic reconstructio...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Thorac Cardiovasc Surg
Main Authors: Hanna, Jennifer M., Keenan, Jeffrey E., Wang, Hanghang, Andersen, Nicholas D., Gaca, Jeffrey G., Lombard, Frederick W., Welsby, Ian J., Hughes, G. Chad
Formato: Artigo
Idioma:Inglês
Publicado: 2015
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5429587/
https://ncbi.nlm.nih.gov/pubmed/26428473
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtcvs.2015.08.079
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares